Mocertatug rezetecan shows promising activity in platinum-resistant ovarian cancer

Reduced dosing frequency of immune checkpoint inhibitors raises survival concerns in advanced cancer

Pembrolizumab improves PFS and QoL in dMMR advanced endometrial cancer

Sacituzumab tirumotecan reduces progression and death in recurrent endometrial cancer

UV1 vaccine combination shows no significant PFS improvement in BRCA wild type recurrent ovarian cancer

Political prioritisation as a driver of vaccine introduction: Evidence from Nigeria’s HPV rollout

Equitable HPV vaccination for all

Biomarker guided PARP inhibitor maintenance improves outcomes in ovarian cancer meta analysis of phase 3 trials

Immune checkpoint inhibitors show setting specific benefit in ovarian cancer meta analysis of 17 randomised trials

Relacorilant chemo combination extends OS in platinum-resistant ovarian cancer

Short-term fasting linked to improved chemo response in advanced ovarian cancer

Aspirin use linked to improved survival in endometrial cancer